Torcetrapib: promising in the treatment of cardiovascular disease

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1434, 2004-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Asymmetric Dimethylarginine (ADMA): A Promising Biomarker for Cardiovascular Disease?

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 2, 2013-01 ,pp. : 180-200

Bentham Science Publishers

Access to resources Recommend Favorite

Natural Products as Promising Therapeutics for Treatment of Influenza Disease

Current Pharmaceutical Design, Vol. 21, Iss. 38, 2015-11 ,pp. : 5573-5588

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Treatment of Obesity in Cardiovascular Disease

By Charakida Marietta Finer Nicholas

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 2, 2012-04 ,pp. : 93-104

Adis International

Access to resources Recommend Favorite

Opportunities for the treatment of inflammation in cardiovascular disease

By Crossman David C

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 11, 2001-11 ,pp. : 1751-1763

Informa Healthcare

Access to resources Recommend Favorite

Garlic for Cardiovascular Disease: Prevention or Treatment?

Current Pharmaceutical Design, Vol. 23, Iss. 7, 2017-04 ,pp. : 1028-1041

Bentham Science Publishers

Access to resources Recommend Favorite